BiotechTube

Fibrin Sealant with 4 IU/ml Thrombin, Vapor-Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4)

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Facial Rhytidectomy (Face-lift)

Conditions

Facial Rhytidectomy (Face-lift)

Trial Timeline

Jun 1, 2008 → Sep 1, 2008

NCT ID
NCT00708071

About Fibrin Sealant with 4 IU/ml Thrombin, Vapor-Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4)

Fibrin Sealant with 4 IU/ml Thrombin, Vapor-Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4) is a phase 2 stage product being developed by Baxter for Facial Rhytidectomy (Face-lift). The current trial status is completed. This product is registered under clinical trial identifier NCT00708071. Target conditions include Facial Rhytidectomy (Face-lift).

What happened to similar drugs?

4 of 8 similar drugs in Facial Rhytidectomy (Face-lift) were approved

Approved (4) Terminated (0) Active (4)
✅BOTOXAbbVieApproved
✅OnabotulinumtoxinA + KYBELLAAbbVieApproved
✅BOTOX®/VISTABEL®AbbVieApproved
✅Erenumab Prefilled SyringeAmgenApproved
🔄EMLA CreamSanofiPhase 3
🔄Botulinum toxin type AIpsenPhase 3
🔄FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00708071Phase 2Completed

Competing Products

13 competing products in Facial Rhytidectomy (Face-lift)

See all competitors
ProductCompanyStageHype Score
BOTOXAbbVieApproved
43
OnabotulinumtoxinA + KYBELLAAbbVieApproved
47
BOTOX®/VISTABEL®AbbVieApproved
43
Erenumab Prefilled SyringeAmgenApproved
43
RapamunePfizerPhase 1
29
EMLA CreamSanofiPhase 3
40
Diflucortolone valerate (BAY866146)BayerPre-clinical
23
Botulinum toxin type AIpsenPhase 3
37
IPN10200 + IPN10200 Placebo + DysportIpsenPhase 1/2
36
IPN59011 + Azzalure + PlaceboIpsenPhase 1
18
Metyrosine + PlaceboBausch HealthPhase 2
21
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30
FMX103 minocycline foam 1.5% + Vehicle foamVyne TherapeuticsPhase 3
30